喫煙は,若い女性の冠動脈の危険因子です
D G Caralis1, U Deligonul, M J Kern
1Department of Internal Medicine, St. Louis University, Mo.
Circulation
|March 1, 1992
まとめ
喫煙は,若い女性の純冠動脈と強く関連しています. この研究では,喫煙者がこの状態を経験する可能性が著しく高かったことが判明しました.
科学分野:
- 心臓病学 心臓病学
- 血管医学 血管医学とは
- 公衆衛生は公衆衛生である.
背景:
- 純粋冠動脈の危険因子については,依然としてほとんど不明です.
- 喫煙は,閉塞性冠動脈疾患の既知の危険因子です.
研究 の 目的:
- 閉経前の女性の喫煙と純粋な冠動脈のとの関連を調査する.
- 低阻塞性冠動脈疾患の流行率を有する集団における純粋冠動脈の潜在的な危険因子を特定する.
主な方法:
- 21人の閉経前女性を対象としたケース・ナビリティ・コントロール研究で,血管学的に冠動脈のが確認された.
- コントロール群 (n=63) は,年齢と人種を合わせた近所の知り合いでした.
- 標準化されたアンケートで,健康,習慣,社会経済的な地位,教育に関するデータを収集した.
主要な成果:
- タバコの喫煙は,対照群 (17.5%) と比較して,症例 (62%) の間で有意により一般的であった.
- 喫煙の確率比は7.7 (95%CI: 2.6-23.1) で,強い関連性を示した.
- すべての症例は,最小限の狭窄症の2人を除いて,正常な基礎動脈動脈血管図を示した.
結論:
- 喫煙と若い女性の純粋な冠動脈のとの間に強い関連性があります.
- タバコの喫煙は,純粋な冠動脈を発症させる重要な危険因子である可能性があります.
さらに関連する動画
05:52Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
Published on: November 4, 2021
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
関連する概念動画
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...